Home LiteratureArticle Details
PMID: 19470470 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.

Proceedings of the National Academy of Sciences of the United States of America ·Vol. 106 ·No. 23 ·2009-06-09 ·Pages 9268-73

Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, Lannigan D, Smith JA, Slingerland JM

Abstract

p90 ribosomal S6 kinase (RSK1) is an effector of both Ras/MEK/MAPK and PI3K/PDK1 pathways. We present evidence that RSK1 drives p27 phosphorylation at T198 to increase RhoA-p27 binding and cell motility. RSK1 activation and p27pT198 both increase in early G(1). As for many kinase-substrate pairs, cellular RSK1 coprecipitates with p27. siRNA to RSK1 and RSK1 inhibition both rapidly reduce cellular p27pT198. RSK1 overexpression increases p27pT198, p27-cyclin D1-Cdk4 complexes, and p27 stability. Moreover, RSK1 transfectants show mislocalization of p27 to cytoplasm, increased motility, and reduced RhoA-GTP, phospho-cofilin, and actin stress fibers, all of which were reversed by shRNA to p27. Phosphorylation by RSK1 increased p27pT198 binding to RhoA in vitro, whereas p27T157A/T198A bound poorly to RhoA compared with WTp27 in cells. Coprecipitation of cellular p27-RhoA was increased in cells with constitutive PI3K activation and increased in early G(1). Thus T198 phosphorylation not only stabilizes p27 and mislocalizes p27 to the cytoplasm but also promotes RhoA-p27 interaction and RhoA pathway inhibition. These data link p27 phosphorylation at T198 and cell motility. As for other PI3K effectors, RSK1 phosphorylates p27 at T198. Because RSK1 is also activated by MAPK, the increased cell motility and metastatic potential of cancer cells with PI3K and/or MAPK pathway activation may result in part from RSK1 activation, leading to accumulation of p27T198 in the cytoplasm, p27:RhoA binding, inhibition of RhoA/Rock pathway activation, and loss of actomyosin stability.

MeSH Terms
Actins/metabolism Cell Line, Tumor Cell Movement Cyclin-Dependent Kinase Inhibitor p27 Cytoplasm/metabolism G1 Phase Humans Intracellular Signaling Peptides and Proteins/metabolism MAP Kinase Signaling System Phosphorylation Ribosomal Protein S6 Kinases, 90-kDa/metabolism Signal Transduction rhoA GTP-Binding Protein/metabolism
Chemicals
Actins CDKN1B protein, human Intracellular Signaling Peptides and Proteins RHOA protein, human Cyclin-Dependent Kinase Inhibitor p27 RPS6KA1 protein, human Ribosomal Protein S6 Kinases, 90-kDa rhoA GTP-Binding Protein
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Larrea Michelle D
Department of Biochemistry and Molecular Biology, Braman Family Breast Cancer Institute, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA.
Hong Feng
Wander Seth A
da Silva Thiago G
Helfman David
Lannigan Deborah
Smith Jeffrey A
Slingerland Joyce M
References (47)
47 references, click to expand
  1. Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization.
    J Biol Chem. 2003 Dec 5;278(49):49254-60 PMID: 14504289
  2. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity.
    Cancer Res. 2006 Feb 15;66(4):2162-72 PMID: 16489017
  3. Biological correlates of p27 compartmental expression in prostate cancer.
    J Urol. 2006 Feb;175(2):528-32 PMID: 16406988
  4. Minimal requirements for the nuclear localization of p27(Kip1), a cyclin-dependent kinase inhibitor.
    Biochem Biophys Res Commun. 2000 Jul 21;274(1):37-42 PMID: 10903892
  5. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Oncol Rep. 2004 Feb;11(2):277-84 PMID: 14719054
  6. Translational control of p27Kip1 accumulation during the cell cycle.
    Science. 1996 Mar 29;271(5257):1861-4 PMID: 8596954
  7. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
    Nat Med. 2002 Oct;8(10):1145-52 PMID: 12244301
  8. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma.
    Cancer Res. 2007 Oct 1;67(19):9238-43 PMID: 17909030
  9. Non-malignant and tumor-derived cells differ in their requirement for p27Kip1 in transforming growth factor-beta-mediated G1 arrest.
    J Biol Chem. 2002 Nov 1;277(44):41686-92 PMID: 12202478
  10. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest.
    J Biol Chem. 1997 Mar 14;272(11):7093-8 PMID: 9054402
  11. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia.
    Cancer Res. 2004 Aug 1;64(15):5225-31 PMID: 15289327
  12. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.
    EMBO J. 1999 Mar 15;18(6):1571-83 PMID: 10075928
  13. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration.
    Nat Med. 1998 Dec;4(12):1449-52 PMID: 9846587
  14. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.
    Cancer Cell. 2005 Jan;7(1):51-63 PMID: 15652749
  15. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype.
    Genes Dev. 2007 Jul 15;21(14):1731-46 PMID: 17626791
  16. Disruption of TGF-beta growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization.
    Oncogene. 2000 Nov 30;19(51):5926-35 PMID: 11127824
  17. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.
    Cell. 2007 Jan 26;128(2):269-80 PMID: 17254966
  18. CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis.
    Mol Biol Cell. 2003 Jan;14(1):201-13 PMID: 12529437
  19. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions.
    Mol Cell Biol. 2003 Jan;23(1):216-28 PMID: 12482975
  20. mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation.
    Mol Cell. 2008 Jun 20;30(6):701-11 PMID: 18570873
  21. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase.
    Nat Cell Biol. 2004 Dec;6(12):1229-35 PMID: 15531880
  22. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Science. 1995 Aug 4;269(5224):682-5 PMID: 7624798
  23. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.
    Cell. 2007 Jan 26;128(2):281-94 PMID: 17254967
  24. The phosphatidylinositol 3-Kinase AKT pathway in human cancer.
    Nat Rev Cancer. 2002 Jul;2(7):489-501 PMID: 12094235
  25. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis.
    Nat Cell Biol. 2007 Feb;9(2):218-24 PMID: 17237771
  26. Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer.
    Cell Cycle. 2004 Aug;3(8):1074-80 PMID: 15280662
  27. p27Kip1 modulates cell migration through the regulation of RhoA activation.
    Genes Dev. 2004 Apr 15;18(8):862-76 PMID: 15078817
  28. Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.
    Cancer Res. 2005 Feb 1;65(3):1027-34 PMID: 15705904
  29. Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest.
    Mol Cell Biol. 2002 May;22(9):2993-3002 PMID: 11940657
  30. The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation.
    Cancer Res. 2005 Apr 15;65(8):3108-16 PMID: 15833840
  31. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.
    Nat Med. 2002 Oct;8(10):1136-44 PMID: 12244303
  32. Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4.
    Mol Cell Biol. 2008 Oct;28(20):6462-72 PMID: 18710949
  33. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.
    Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):632-7 PMID: 15701850
  34. Regulation of an epitope-tagged recombinant Rsk-1 S6 kinase by phorbol ester and erk/MAP kinase.
    Biochemistry. 1993 Aug 3;32(30):7727-38 PMID: 7688567
  35. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway.
    J Biol Chem. 2004 Jan 16;279(3):1885-91 PMID: 14559914
  36. Akt1 sequentially phosphorylates p27kip1 within a conserved but non-canonical region.
    Cell Div. 2006 Jun 16;1:11 PMID: 16780593
  37. New functional activities for the p21 family of CDK inhibitors.
    Genes Dev. 1997 Apr 1;11(7):847-62 PMID: 9106657
  38. Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein bad.
    Cancer Res. 2003 Dec 1;63(23):8330-7 PMID: 14678993
  39. C-terminal phosphorylation controls the stability and function of p27kip1.
    EMBO J. 2006 Nov 1;25(21):5159-70 PMID: 17053782
  40. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.
    Microbiol Mol Biol Rev. 2004 Jun;68(2):320-44 PMID: 15187187
  41. Regulation of p27Kip1 by miRNA 221/222 in glioblastoma.
    Cell Cycle. 2007 Aug 15;6(16):2005-9 PMID: 17721077
  42. 14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1).
    EMBO J. 2004 May 5;23(9):1934-42 PMID: 15057270
  43. IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase.
    EMBO J. 1997 Jun 2;16(11):3133-44 PMID: 9214631
  44. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.
    Genes Dev. 1998 Nov 15;12(22):3499-511 PMID: 9832503
  45. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.
    Nat Rev Cancer. 2008 Apr;8(4):253-67 PMID: 18354415
  46. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest.
    Nat Med. 2002 Oct;8(10):1153-60 PMID: 12244302
  47. Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity.
    Mol Cell Biol. 2008 Jan;28(1):498-510 PMID: 17908796
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
DOI
10.1073/pnas.0805057106
Published
2009-06-09
Epub
2009-00-22
Pages
9268-73
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC2695095
Subset
IM
Grants
NCI NIH HHS · F31 CA113284 · United States
NCI NIH HHS · R01 CA105118 · United States
NCI NIH HHS · 5F31CA113284 · United States
NCI NIH HHS · 1R01CA105118-01 · United States
External Links
PubMed source DOI: 10.1073/pnas.0805057106 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2